Remdesivir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Remdesivir
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Remdesivir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 2 USDMF, 1 EU WC, 3 KDMF, 8 NDC API, 8 Listed Suppliers, $ API Reference Price

18 API Suppliers
2 USDMF
1 EU WC
3 KDMF
8 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

213 Drugs in Development

213 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 2 FDA Orange Book, 1 Canada, 2 Listed Dossiers

5 FDF Dossiers
2 FDA Orange Book
1 Canada
2 Listed Dossiers

DIGITAL CONTENT

629 News #PharmaBuzz

629 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Annual Reports

1 US Medicaid Prescriptions
5 Annual Reports

MARKET PLACE

25 APIs, 4 FDF Dossiers, 2 Intermediates

25 APIs
4 FDF Dossiers
2 Intermediates

PATENTS & EXCLUSIVITIES

71 US Patents, 16 US Exclusivities, 7 Health Canada Patents

71 US Patents
16 US Exclusivities
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ API Ref.Price (USD/KG) : 31,373 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Gilead Sciences Canada Inc.

filter Patent Reset all filters

7 All

01 22722177

02 22804840

03 22963832

04 12998189

filter Product Reset all filters

7 All

01 7REMDESIVIR

filter Dosage Reset all filters

7 All

01 4POWDER FOR SOLUTION

02 3SOLUTION

filter Exp Date Reset all filters

7 All

01 22029-04-22

02 22031-07-22

03 22035-10-29

04 12036-09-16

Product Main Page

01

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-22

Date Granted : 2018-09-11

Brand Name : VEKLURY

Patent Number : 2804840

Filing Date : 2011-07-22

Strength per Unit : 100 mg / 20mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2031-07-22

Date Granted : 2018-09-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-10-29

Date Granted : 2020-06-16

Brand Name : VEKLURY

Patent Number : 2963832

Filing Date : 2015-10-29

Strength per Unit : 100 mg / 20mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2035-10-29

Date Granted : 2020-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-22

Date Granted : 2016-08-16

Brand Name : VEKLURY

Patent Number : 2722177

Filing Date : 2009-04-22

Strength per Unit : 100 mg / 20mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2029-04-22

Date Granted : 2016-08-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-10-29

Date Granted : 2020-06-16

Brand Name : VEKLURY

Patent Number : 2963832

Filing Date : 2015-10-29

Strength per Unit : 100 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2035-10-29

Date Granted : 2020-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-22

Date Granted : 2016-08-16

Brand Name : VEKLURY

Patent Number : 2722177

Filing Date : 2009-04-22

Strength per Unit : 100 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2029-04-22

Date Granted : 2016-08-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-22

Date Granted : 2018-09-11

Brand Name : VEKLURY

Patent Number : 2804840

Filing Date : 2011-07-22

Strength per Unit : 100 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2031-07-22

Date Granted : 2018-09-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gilead Sciences Canada Inc.

Remdesivir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-09-16

Date Granted : 2021-08-03

Brand Name : VEKLURY

Patent Number : 2998189

Filing Date : 2016-09-16

Strength per Unit : 100 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2036-09-16

Date Granted : 2021-08-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!